www.medicaldaily.com

www.medicaldaily.com
Share

www.medicaldaily.com

 •  February 14

A group of myeloid cells that are able to strongly suppress the immune system and aid cancerous tumors have finally met their match in the form of a peptide that binds to and destroys them, without damaging the surrounding tissue. The research paper was published in Nature Medicine. In a press release, senior author Dr. Larry Kwak, director of the...

www.medicaldaily.com

 •  February 14

There have been some monumental advances in eradicating malaria from the world as of late. The World Health Organization (WHO) recently released its World Malaria Report stating that the past decade has seen over 3.3 million lives saved from the sometimes deadly mosquito-borne disease. Furthering these prospects of ridding the world of malaria, a...

www.medicaldaily.com

 •  February 14

A new protein structure has been developed inside a laboratory that could help more accurately target diseased targets and increase a drug’s potency. Swiss researchers at the Laboratory of Therapeutic Proteins and Peptides at Ecole Polytechnique Federale De Lausanne (EPFL) have discovered a new synthetic amino acid that can be used for a whole new...

www.medicaldaily.com

 •  February 14

Valtrex is a drug commonly prescribed to people with genital herpes. It won’t cure herpes, but it works to prevent breakouts, including sores and blisters. But in an interesting (small) trial, Valtrex additionally benefitted HIV-1 infection. HIV-1 and HIV-2 share similarities, but it’s believed HIV-2 is harder to pass on to another person and is...

www.medicaldaily.com

 •  February 14

Here’s a quick reminder on fat, if you needed it: We have both brown and white. You probably know the white fat, because it’s the one that shows on your belly and your thighs. It’s the fat that stores energy as large droplets, contributing to obesity. Brown fat, however, is special. When we’re born, about five percent of the fat on our bodies are...

www.medicaldaily.com

 •  February 14

Death rates for outbreaks of hemorrhagic fever, including Ebola, are tragically high — more than 90 percent of those infected die. Yet, no vaccine exists to prevent these terrifying illnesses, which even cause bleeding from the eyes. One important thing scientists know about hemorrhagic fevers is they are caused by filoviruses, an emerging family...

www.medicaldaily.com

 •  February 14

German researchers have found that geranium extracts can inhibit HIV type 1 by preventing the virus from invading human cells, raising the possibility that the next big thing in AIDS prevention may be found in your own backyard. The new study, which is published in the journal PLOS ONE, shows that the extracts from the geranium plant Pelargonium...

www.medicaldaily.com

 •  February 14

Half of the world’s population is at risk for malaria, according to the World Health Organization — and new science is one step closer to developing a vaccine for this life-threatening disease. Malaria is transmitted by Plasmodium falciparum, a parasite a person gets when bitten by an infected mosquito. The parasite goes from one red blood cell to...

www.medicaldaily.com

 •  February 14

SHANGHAI (Reuters) - China had more than 18,500 drugs waiting for approval at the end of 2014, up by a third from a year before, the official Center for Drug Evaluation said on Friday, reflecting industry concern that it is getting harder to get medicines approved in the China market. Drug company executives say China has toughened the approval...

www.medicaldaily.com

 •  February 14

Research out of the University of Michigan and Purdue University has found an important aspect of how both the dengue virus and West Nile virus replicate in their host cells. The scientists believe this will lead to a better understanding of how the virus infects humans, and ultimately to the development of a vaccine. Janet Smith and her team...